SCHEMBL18862269

SCHEMBL18862269

CN1CCC(N(C)Cc2ccc(-c3ccccc3[N+](=O)[O-])o2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.52
▸ NOS1 P29475 1/20 0.52
▸ NOS2 P35228 1/20 0.52
▸ IL33 O95760 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MAPT P10636 5/20 0.44
▸ MAPK1 P28482 5/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ APAF1 O14727 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ TDP1 Q9NUW8 3/20 0.43
▸ PKM P14618 1/20 0.43
▸ PDE4B Q07343 2/20 0.41
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6394577 0.77 ALDH1A1 (0.47) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL18862282 0.76 IL33 (0.46) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL18862279 0.74 IL33 (0.52) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL16316318 0.72 ALDH1A1 (0.49) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL18862278 0.70 MAPT (0.59) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL623536 0.70 ALDH1A1 (0.52) KMT2AMAPTMAPK1ALDH1A1NPC1
SCHEMBL622199 0.70 ALDH1A1 (0.49) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL13719371 0.69 ALDH1A1 (0.46) IL33KMT2AMAPTMAPK1ALDH1A1
SCHEMBL3400235 0.69 ALDH1A1 (0.59) KMT2AMAPTMAPK1ALDH1A1NPC1
SCHEMBL18862272 0.68 IL33 (0.55) IL33KMT2AMAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017083242-A1 INHIBITORS OF SUPPRESSION OF TUMORIGENCITY 2 (ST2) AND METHODS USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-05-18 — — WO disclosed
Send feedback